Understanding a child’s unique way of experiencing the world is key to their growth and development. Aignosis, an AI-powered platform, is transforming how families identify and address neurodevelopmental concerns like autism from the comfort of their homes. With innovative tools designed to deliver accuracy and reliability, Aignosis is paving the way for accessible, non-invasive insights. Aignosis Shark Tank India Season 4 unique pitch earned the support of multiple Sharks, leading to an exceptional investment deal. Here’s a comprehensive look at Aignosis’ journey, their cutting-edge tools, and their plans for the future.
Know About Aignosis
Aignosis leverages advanced AI-powered tools to help parents understand their child’s behavior and developmental needs. Their technology enables early detection of signs of autism and other neurodevelopmental conditions, empowering families with timely insights that can make a world of difference. Key features of Aignosis include:
- AI-Driven Analysis: Provides personalized insights into a child’s developmental patterns.
- Non-Invasive: Designed to work seamlessly at home without causing stress or discomfort.
- User-Centric Design: Focused on delivering accurate results while keeping the family’s needs in mind.
You can also check the Rosha India Shark Tank India Season 4 pitch.
Aignosis Pitch Shark Tank India Season 4 Pitch
The founders of Aignosis brought their vision to life on the Shark Tank India Season 4 stage, showcasing how their AI-driven platform addresses critical gaps in neurodevelopmental awareness and diagnosis. Their mission to provide families with accessible, early-stage insights into their child’s development resonated deeply with the Sharks.
Investment Details
| Company | Aignosis |
| Founders | Divyansh Mangal, Raksheet Jain |
| Website | https://aignosis.in/ |
| Season | Shark Tank India Season 4 |
| Original Ask | ₹ 50 Lakhs for 4% Equity at a ₹12.5 Crore Valuation |
| Investment Secured | Yes |
| Deal | ₹ 1 Crore for 8% Equity |
| Investors | Peyush Bansal, Aman Gupta and Varun Dua |
Aignosis Winning Moment
Peyush Bansal, Aman Gupta, and Varun Dua recognized the game-changing potential of Aignosis in addressing neurodevelopmental challenges. Their collaborative investment of ₹ 1 Crore for 8% equity reflects their shared commitment to fostering innovation in the health tech space. With their guidance, Aignosis is poised to scale its operations and impact even more families.
Why Aignosis Stands Out
- Innovative Technology: AI-powered tools designed for early detection and personalized insights set Aignosis apart.
- Accessibility: The non-invasive, home-based model ensures that families can use the tools conveniently.
- Social Impact: By promoting early awareness and intervention, Aignosis is driving a positive change in the field of neurodevelopmental health.
What’s Next for Aignosis?
With support from Peyush Bansal, Aman Gupta, and Varun Dua, Aignosis plans to:
- Expand their platform’s capabilities to address a wider range of developmental concerns.
- Build awareness about the importance of early detection through strategic campaigns.
- Strengthen their technology to deliver even more accurate and reliable results.
